Presentations include seven company-sponsored abstracts and two investigator-initiated studies Oral presentation to highlight new analysis comparing volumetric and bidirectional assessments in ...

Voranigo is rapidly adopted for IDH-mutated glioma, addressing unmet needs and shifting towards earlier intervention. Retrospective analysis identified 520 patients treated with Voranigo, with 41% ...